1. Introduction {#s0005}
===============

The hypothalamus integrates signals from peripheral tissues and central nodes to regulate feeding, energy balance, nutrient flux, and counterregulatory responses that maintain nutrient homeostasis [@bib1]. Insulin is secreted from the pancreatic beta-cells during meals to promote peripheral nutrient homeostasis [@bib2]; however, it also modulates energy and glucose homeostasis by acting on hypothalamic and dopaminergic neurons [@bib3]. By comparison, leptin produced by adipocytes is a dominant signal that informs the brain about peripheral energy stores [@bib4]. Leptin binds to the long form of the leptin receptor (LepRb) found largely---but not entirely---on hypothalamic neurons [@bib5]. LepRb neurons sense and integrate signals relevant to nutrient homeostasis to control satiety, energy balance and metabolism [@bib4]. LepRb generates multiple downstream signals by activating JAK2 and recruiting SHP2, STAT3 and STAT5, along with SH2B, Irs1/2 and Irs4 [@bib6; @bib7].

The insulin receptor substrates (Irs1, 2, 3 and 4) are principle targets for the insulin and IGF1 receptor tyrosine kinases, which play a central role in somatic growth and metabolic regulation [@bib8]. IRS-proteins are also phosphorylated by the receptors for some cytokines (IL4, IL9, IL13), growth hormone and leptin in various cells and tissues [@bib7; @bib9; @bib10; @bib11; @bib12; @bib13; @bib14]. The IRS-proteins share a common structure, including an NH~2~-terminal pleckstrin homology (PH) domain followed by a phosphotyrosine binding (PTB) domain, and a tail containing many Tyr and Ser/Thr phosphorylation sites. The PH and PTB domains mediate recruitment to appropriate activated receptors in the plasma membrane [@bib15; @bib16]. Although the COOH-terminal amino acid sequences of the various IRS-proteins diverge significantly, multiple short tyrosine phosphorylation motifs can bind and activate similar SH2-domain containing proteins, including the type 1 phosphatidylinositol 3-kinase [@bib17].

The various IRS-proteins have distinct physiologic functions. These differences in biological specificity among the various Irs-proteins may be conferred by sequence divergence or by differences in patterns of expression. Irs1 and Irs2 are widely expressed in mammalian tissues, whereas Irs3 is largely restricted to nonhuman adipose tissue (where it promotes adipogenesis [@bib18; @bib19]). Although some reports describe a role for Irs4 in regenerating liver and hepatocellular carcinoma [@bib20; @bib21; @bib22], Irs4 is expressed mainly in the hypothalamus in healthy animals [@bib23; @bib24; @bib25]. Potential overlap in the expression of Irs1 and Irs2 with Irs4 appears to occur mainly in neurons of the ventral hypothalamus [@bib24]. Based upon genetic deletion experiments, Irs1 promotes embryonic and postnatal body growth, and mediates insulin sensitivity in classical insulin target tissues [@bib26]. By comparison, Irs2 mediates several important functions that are not shared with Irs1---including pancreatic beta-cell growth and survival, CNS/hypothalamic nutrient sensing, endothelial cell function, and sensitivity to neurodegenerative disease [@bib27; @bib28; @bib29]. Irs1^−/−^ mice develop insulin resistance that is compensated by elevated circulating insulin and β-cell/islet growth, whereas Irs2^−/−^ mice develop diabetes owing to the combined effects of insulin resistance and the progressive loss of pancreatic β-cells [@bib30]. Together Irs1 and Irs2 apparently mediate some essential functions, since mice null for both genes die before weaning [@bib8].

The deletion of Irs2 specifically in the CNS can extend life span while producing early-onset obesity, insulin resistance and glucose intolerance [@bib31; @bib32]. The metabolic phenotypes resulting from Irs2 ablation are at least in part attributable to Irs2 function in a relatively small subset of LepRb-expressing neurons in the brain [@bib29]. In contrast, while Irs4 is highly conserved and displays a very specific and restricted pattern of expression that overlaps with LepRb cells in the ventral hypothalamus, the deletion of Irs4 alone has very mild or no effects upon energy balance or glucose metabolism in mice [@bib33]. To reveal a potential physiological function for Irs4 in the CNS, we intercrossed mice without Irs2 in the brain (*bIrs2*^*−*/*−*^--mice) with whole-body *Irs4*^*−*/*y*^ mice to generate compound male *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice. We examined energy balance and metabolism in these mice, and also investigated whether there is a functional role for Irs4 in LepRb neurons.

2. Material and methods {#s0010}
=======================

2.1. Animals {#s0015}
------------

Generation of Irs4-deficient mice. The *Irs4* gene was obtained by screening a genomic DNA library derived from mouse 129/Sv embryonic stem (ES) cells. A DNA fragment was ligated to the pPNT vector 5′ to the *neo* cassette. The *neo* gene was flanked by EcoRv-*Avr* II fragment and *Clal*-*Spel* fragment derived from the *Irs-4* regions 5′ and 3′ to the deleted coding region. The Irs4 targeting vector was introduced into R1 ES cells by electroporation. The transfectants were selected with neomycin (G418) and ganciclovir. *Irs4*^*+*/*−*^ heterozygous ES cells were injected into C57BL/6 blastocysts. The chimeric male mice were bred with female wild-type C57BL/6 mice. Because the *Irs-4* gene is on the X chromosome, this breeding yielded female mice heterozygous for *Irs-4* disruption and male wild-type mice. The detailed breeding strategy is described in [Section 3](#s0045){ref-type="sec"}. *Lepr*^*∆Irs2*^, *bIrs2*^*−*/*−*^ and *Irs2*^*L*/*L*^ were described previously [@bib29; @bib31]. Mice were bred in our colony at Boston Childrens Hospital or at the Harvard School of Public Health. All animals were handled in accordance with all procedures approved by the appropriate Institutional Animal Care and Use Committee (IACUC). Animals were fed breeder chow diet containing 9 kcal %fat (Research diets, Inc).

2.2. Metabolic analysis {#s0020}
-----------------------

Lean and fat body mass were assessed by Dual-Energy X-ray Absorptiometry (DEXA, GE Lunar Corp.) as previously described [@bib34]. Blood glucose levels were measured on random-fed or overnight-fasted animals in mouse-tail blood using Glucometer Elite (Bayer). Intraperitoneal glucose tolerance test was performed on mice fasted for 16 h overnight. Animals were then injected intraperitoneally with [d]{.smallcaps}-glucose (2 g/kg) and blood glucose levels were measured [@bib35]. For insulin tolerance tests, mice were fasted for a 4-h period in the light cycle before ip injections of insulin (Humulin R, 0.8 U/kg) diluted in sterile saline. Blood glucose concentrations were measured at indicated time points. Blood insulin and leptin levels were determined on serum from tail vein bleeds using a Rat Insulin ELISA kit and Mouse Leptin ELISA kit (Crystal Chem. Inc.). For food intake measurements mice were housed individually and food intake was measured for 2 consecutive days.

2.3. Histology and morphometric analysis {#s0025}
----------------------------------------

Histological analysis was performed on various tissues isolated from the animals as previously described [@bib36]. Morphometric analysis of gonadal white adipose tissue from 400 cells from 4 different animals per genotype was performed with NIH ImageJ software (<http://rsb.info.nih.gov/ij/>). The determination of islet area was done by measuring and counting islets from non-overlapping pictures that covered the entire pancreas section area. Measurements were corrected to the total area of the pancreas section in square microns, which was calculated using SPOT software.

2.4. Energy expenditure {#s0030}
-----------------------

As previously described [@bib37], physical activity and energy expenditure were performed over a 72 h period with a Comprehensive Laboratory Animal Monitoring System (CLAMS, Oxymax Windows 3.0.3; Columbus Instruments, OH, USA). Mice were housed individually at room temperature (22 °C) under an alternating 12 h light/12 h dark cycle. Heat production was measured and analyzed by generalized linear regression to determine the energy expenditure.

2.5. RNA extraction and qPCR {#s0035}
----------------------------

Total RNA was extracted from brown adipose tissue or from hypothalamus using Trizol (Gibco BRL) and 1 µg samples were converted to cDNA using the iscript cDNA kit (Bio-Rad Laboratories Inc.). Sample cDNAs were analyzed in triplicate via quantitative RT-PCR for *Pomc* and *Agrp* in hypothalamus with customized primers as previously described [@bib37]. Actin gene expression was used to normalize RNA content and the relative gene product amounts were reported as mean±SEM of several animals.

2.6. Statistical analysis {#s0040}
-------------------------

Unless otherwise stated mean values±SEM were used to make comparisons between 2 groups; significance was determined by a Student\'s *t*-test. A *p*-value less than 0.05 was considered statistically significant. Generalized linear regression (SPSS, v 19) was used to identify significant differences in body weight and energy expenditure.

3. Results {#s0045}
==========

3.1. Generation of *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice {#s0050}
----------------------------------------------------------

The Irs4 targeting vector was generated by standard methods and used for homologous recombination in 129/Sv embryonic stem cells ([Figure S1](#s0085){ref-type="sec"}). The Novartis Gene Atlas and Allen Brain Atlas confirm that Irs4 expression is largely restricted to the ventral hypothalamus, so the conventional whole body Irs4 knock-out is in practice restricted to the CNS ([Figure S2](#s0085){ref-type="sec"}) [@bib38]. Because the *Irs4* gene is on the X chromosome, there are no heterozygous knockout males. Heterozygous females and wild-type males were bred to obtain *Irs4*^*−*/*y*^ males and *Irs4*^*+*/*−*^ females as well as wild-type males and females. The *Irs4*^*−*/*y*^ males and heterozygous females from this breeding were mated to obtain female heterozygous and *Irs4*^*−*/*−*^ mice, as well as male wild-type and *Irs4*^*−*/*y*^ mice. To focus our study on the interaction between Irs2 and Irs4 in the CNS, we utilized previously published nestin-cre transgenic mice intercrossed to loxP-flanked alleles to delete *Irs2*^*L*/*L*^ specifically in neurons (*bIrs2*^*−*/*−*^) [@bib31]. Mice with a combined deficiency of Irs2 and Irs4 were generated by intercrossing female *bIrs2*^*+*/*−*^·*Irs4*^*+*/*−*^ mice with male *bIrs2*^*−*/*+*^·*Irs4*^*−*/*y*^ mice to produce male *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ and female *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice, as well as control genotypes. There was no detectable embryonic lethality or early death associated with the Irs4 null phenotype, and the male *Irs4*^*−*/*y*^ and female *Irs4*^*−*/*−*^ mice were fertile and displayed normal size and a healthy appearance.

3.2. Growth and energy balance in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice {#s0055}
-----------------------------------------------------------------------

The body weight of male control (*Irs2*^*L*/*L*^), *Irs4*^*−*/*y*^, *bIrs2*^*−*/*−*^, or *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice were monitored between 6 and 13 weeks of age to determine whether Irs4 interacts with neuronal Irs2 for body weight regulation. Compared to control mice (*Irs2*^*L*/*L*^), the whole body *Irs4*^*−*/*y*^ mice grew to a normal size between 6 and 13 weeks of age ([Figure 1](#f0005){ref-type="fig"}A). As shown previously [@bib31], *bIrs2*^*−*/*−*^ mice were heavier and longer with significantly increased body fat compared with *Irs2*^*L*/*L*^ mice ([Figure 1](#f0005){ref-type="fig"}A and D). Through 12 weeks of age, the lack of Irs4 had no effect on body weight compared against the control mice; however, male *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice were 60% heavier than *Irs2*^*L*/*L*^ and 20% heavier than *bIrs2*^*−*/*−*^ animals ([Figure 1](#f0005){ref-type="fig"}A and B). Dual X-ray absorptometry (DEXA) confirmed that the obesity phenotype of *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice was due to significantly increased adipose mass compared to obese *bIrs2*^*−*/*−*^ mice ([Figure 1](#f0005){ref-type="fig"}D). Hematoxylin and eosin staining of 6-month-old mice confirmed that the adipocytes of *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice were 20% larger (*p*\<0.05) than *bIrs2*^*−*/*−*^ mice ([Figure 2](#f0010){ref-type="fig"}A and B). Moreover, 9 month old *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice displayed hepatic steatosis similar to that of *ob*/*ob* mice; however, steatosis was never observed in *Irs4*^*−*/*y*^, *bIrs2*^*−*/*−*^ or control mice ([Figure 2](#f0010){ref-type="fig"}C).

Consistent with the graded adiposity of the *bIrs2*^*−*/*−*^ and *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^-mice, leptin concentrations were elevated in adult *bIrs2*^*−*/*−*^-mice and significantly greater in the *bIrs2*^*−*/*−*^·*Irs4*^*-*/*y*^ mice; however, the leptin concentration was normal in the *Irs4*^*-*/*y*^*-*mice ([Figure 3](#f0015){ref-type="fig"}A). Food intake by chow-fed controls- and *Irs4*^*−*/*y*^*-mice* was indistinguishable, whereas *bIrs2*^*−*/*−*^-mice consumed more food ([Figure 3](#f0015){ref-type="fig"}B). The *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^-mice consumed approximately 10% more food than the *bIrs2*^*−*/*−*^-mice during the 24-h test interval ([Figure 3](#f0015){ref-type="fig"}B). Thus, the lack of Irs4 augmented hyperphagia only when Irs2 was also absent from the CNS.

Food intake and energy expenditure must be coordinately regulated to maintain energy balance and stable body weight. Irs2 was previously shown to alter energy homeostasis as young *bIrs2*^*−*/*−*^ mice were less active and consumed less oxygen than age-matched control mice [@bib31]. At 3 months of age, individually housed animals were monitored for 72 h in the Comprehensive Lab Animal Monitoring System (CLAMS). During the dark cycle, O~2~ consumption and heat generation were reduced similarly in *bIrs2*^*−*/*−*^ and *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice compared to the normal parameters of *Irs4*^*−*/*y*^ and control mice ([Figure 3](#f0015){ref-type="fig"}C and D). Respiratory exchange ratio (RER) was not different between the groups ([Figure 3](#f0015){ref-type="fig"}E). Nevertheless, compared against *bIrs2*^*−*/*−*^ mice the hematoxylin and eosin stained brown adipose tissue (BAT) of adult 6-month-old *bIrs2*^*−*/*−*^·*Irs4*^*-*/*y*^-mice contained larger lipid-filled vacuoles that resembled white adipocytes ([Figure 3](#f0015){ref-type="fig"}F). Since Irs2 signaling was previously shown to play a role in BAT thermoregulation, these findings reveal a link between central Irs4 and BAT function that was exposed when Irs2 was deleted in the CNS [@bib29].

3.3. Hypothalamic neuropeptide expression {#s0060}
-----------------------------------------

To test whether the hyperphagia and obesity of *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^-mice were related to changes in hypothalamic neuropeptide expression, we measured expression of *Npy*, *Agrp*, and *Pomc* mRNA in the ARC by qPCR [@bib3]. The expression of mRNA encoding orexigenic neuropeptides (*Npy* and *Agrp*) was increased in *bIrs2*^*−*/*−*^ and *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^-mice, consistent with the observed hyperphagia of these animals ([Figure 4](#f0020){ref-type="fig"}A and B). By comparison, there were no significant changes in the expression of *Pomc* mRNA among the various genotypes ([Figure 4](#f0020){ref-type="fig"}C). Overall, the ratio between orexigenic (*Agrp*) and anorexigenic (*Pomc*) mRNAs was similarly increased in *bIrs2*^*-*/*-*^ and *bIrs2*^*-*/*-*^·*Irs4*^*−*/*y*^ mice compared to *Irs4*^*−*/*y*^ and control mice ([Figure 4](#f0020){ref-type="fig"}D). Thus the mRNA expression of these hypothalamic neuropeptides was regulated by brain Irs2, but not influenced by Irs4.

3.4. Glucose homeostasis in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice {#s0065}
-------------------------------------------------------------------

Next, we investigated whether Irs4 synergizes with neuronal Irs2 to control systemic glucose homeostasis. Fasting glucose concentrations were normal in 3 month-old *Irs4*^*−*/*y*^ mice, but slightly increased in *bIrs2*^*−*/*−*^ mice and more dramatically increased in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-mice* ([Figure 5](#f0025){ref-type="fig"}A). Similarly, ad libitum-fed blood glucose values trended upward in the *Irs4*^*−*/*y*^ *and bIrs2*^*−*/*−*^ mice, but only reached significance in the *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-mice* ([Figure 5](#f0025){ref-type="fig"}B). Whereas glucose tolerance was normal in *Irs4*^*−*/*y*^*-*mice and only slightly impaired in *bIrs2*^*−*/*−*^-mice, *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ *mice* displayed dramatic glucose intolerance ([Figure 5](#f0025){ref-type="fig"}C). Furthermore, the *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice were resistant to the hypoglycemic effects of exogenous insulin, whereas the responses of *bIrs2*^*−*/*−*^ and *Irs4*^*−*/*y*^ mice were not significantly different from controls ([Figure 5](#f0025){ref-type="fig"}D). The HOMA2-IR confirmed that insulin resistance persists in 9 month old *bIrs2*^*−*/*−*^·*Irs4*^*-*/*y*^ and *bIrs2*^*−*/*−*^-mice, whereas *Irs4*^*−*/*y*^ mice displayed normal insulin sensitivity ([Figure 5](#f0025){ref-type="fig"}E). Consistent with these results, *Irs4*^*−*/*y*^*-mice* displayed normal insulin concentrations, whereas the *bIrs2*^*−*/*−*^-mice displayed slightly elevated circulating insulin at 9 months of age, whereas insulin concentrations in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^-mice were elevated approximately 5-fold ([Figure 5](#f0025){ref-type="fig"}F). The *bIrs2*^*−*/*−*^ mice at 3.5 months displayed 3-fold greater β-cell mass, which was consistent with the demand for compensatory insulin secretion ([Figure 6](#f0030){ref-type="fig"}A). By comparison, the beta cell mass of 3.5 month old *bIrs2*^*−*/*−*^ mice and 7.5 month old *Irs4*^*−*/*y*^ mice was indistinguishable from the controls.

3.5. Irs4 effects on obesity are independent of leptin receptor expressing neurons {#s0070}
----------------------------------------------------------------------------------

Leptin, a hormone produced by adipocytes, acts upon leptin receptor (LepRb) expressing neurons to modulate energy homeostasis [@bib4]. Our recent observations show that deletion of Irs2 in LepRb neurons (*Lepr*^*∆Irs2*^-mice) increases body weight through the combined effects of hyperphagia and reduced energy consumption [@bib29]. Since others have suggested that Irs4 mediates PI 3-kinase signaling in response to leptin stimulation [@bib7], it is possible that the synergy between Irs4 and Irs2 occurs in LepRb neurons and that the deletion of Irs4 would increase the obesity observed in *Lepr*^*∆Irs2*^-mice. However, at 3 months of age the increased body weight of the *Lepr*^*∆Irs2*^*-*mice was not further increased in the *Lepr*^*∆Irs2*^·*Irs4*^*−*/*y*^ *mice* ([Figure 7](#f0035){ref-type="fig"}A). Furthermore, while ad libitum-fed blood glucose levels were significantly elevated in the *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice relative to all other groups (See [Figure 5](#f0025){ref-type="fig"}B, above), blood glucose levels remained unchanged among *Lepr*^*∆Irs2*^, *Lepr*^*∆Irs2*^·*Irs4*^*−*/*y*^ and controls ([Figure 7](#f0035){ref-type="fig"}B). Thus, the synergy between brain Irs2 and Irs4 for body weight control occurs in neurons that are distinct from LepRb cells.

4. Discussion {#s0075}
=============

Compared to Irs1 and Irs2, for which genetic ablation yields substantial phenotypes, the physiologic role of Irs4 has been difficult to establish because the deletion of Irs4 alone produces minimal physiologic perturbation [@bib33]. Since Irs1 and Irs2 are widely expressed, while the expression of Irs4 is more narrowly distributed (largely in the hypothalamus, where Irs2 plays a crucial role in metabolic homeostasis), we reasoned that Irs2 and Irs4 might play synergistic and somewhat redundant roles. Indeed, insulin continues to stimulate the phosphorylation of AKT, a major IRS-protein-dependent insulin signaling pathway, in hypothalamic extracts from *bIrs2*^*−*/*−*^ animals [@bib31], suggesting the persistent and compensatory action of a second IRS-protein in the hypothalamus.

We thus examined the possibility of functional cooperation between Irs2 and Irs4 in the brain by combining whole body Irs4 deletion (which is functionally brain-restricted) with brain-specific Irs2 deletion thereby focusing on the tissue relevance for any synergistic action and avoiding the potentially confounding phenotypes associated with deletion of Irs2 in other tissues (such as the islet). Indeed, this analysis revealed important functional synergy between brain Irs2 and Irs4 in the regulation of energy balance and glucose homeostasis: To an extent far greater than either deletion alone, the brain-wide ablation of Irs2 and Irs4 in combination promoted obesity and glucose intolerance. The severe metabolic phenotype in the *bIrs2*^*-*/*-*^·*Irs4*^*-*/*y*^ mice thus reveals an important physiological role for Irs4 that is obscured by the continued presence of Irs2 in the *Irs4*^*−*/*y*^-mice [@bib33], much as the presence of Irs4 mitigates partially the phenotype produced by CNS-specific Irs2 deletion in *bIrs2*^*−*/*−*^ animals. The concerted action of Irs2 and Irs4 contributes not only to overall adiposity and glucose intolerance, but plays an especially crucial role in the control of insulin action and hepatic lipid accumulation, as islet size, HOMA2-IR and hepatic steatosis are dramatically elevated in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice, but do not differ from controls in the single mutant (*bIrs2*^*−*/*−*^ and *Irs4*^*−*/*y*^) mice.

Our current results, together with previous data, reveal separable functions for Irs2 and Irs4 expression in distinct neural subsets. The brain-wide ablation of Irs2 suffices to increase *Agrp* and *Npy* expression relative to *Pomc*, and promotes obesity and glucose intolerance. LepRb-restricted disruption of Irs2 expression similarly results in increased *Agrp* and *Npy* (and decreased *Pomc*) expression [@bib29]. The *Lepr*^*∆Irs2*^-mice also display increased adiposity and decreased glucose tolerance relative to controls, although the magnitude of their metabolic phenotype is more modest than that observed in *bIrs2*^*−*/*−*^ animals[@bib29]. These findings suggest that while Irs2 signaling in LepRb cells modulates *Agrp*, *Npy* and *Pomc* expression and contributes to the control of glucose and energy homeostasis, Irs2 acts in other (non-LepRb) neurons to mediate additional aspects of metabolic control.

While Irs4 cooperates with Irs2 in the CNS to modulate energy balance and glucose homeostasis, Irs4 does not contribute to the control of *Agrp*, *Npy*, or *Pomc* expression; nor does the absence of Irs4 exacerbate the phenotype of *Lepr*^*∆Irs2*^-mice as it does the metabolic dysfunction of *bIrs2*^*−*/*−*^ animals. Thus, our data are consistent with the idea that Irs4 synergizes with Irs2 in non-LepRb neurons to control energy balance and metabolism independently of LepRb neurons and the leptin-modulated ARC Pomc and AgRP/Npy neurons. In the future, it will be important to identify the relevant Irs2/Irs4-expressing non-LepRb cells to reveal their neurophysiologic function and independent roles in the control of metabolic homeostasis. Given the distribution of Irs4 and LepRb, it is tempting to speculate that the crucial Irs4-expressing neurons could lie in the paraventricular hypothalamic nucleus (PVH), which is crucial for energy balance and metabolism, but which contains little LepRb.

Importantly, while Irs4 may not synergize with Irs2 in LepRb neurons, it remains possible (especially given the distribution of *Irs4* expression in the hypothalamus) that LepRb neurons contain Irs4. The lack of metabolic phenotype for *Irs4*^*−*/*y*^ mice and lack of synergy between Irs2 and Irs4 in LepRb neurons suggests that if Irs4 plays a role in LepRb neurons, however, the function of Irs4 in LepRb cells must be redundant with a protein other than Irs2, such as Irs1. Thus, it may be useful to explore potentially redundant roles for Irs1 and Irs4 in the future, including in LepRb neurons.

Previous studies suggest that Irs4 might play a role in cellular leptin action [@bib7]. Serum leptin concentrations are normal in *Irs4*^*−*/*y*^-mice, however. Furthermore, while leptin is elevated in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ relative to *bIrs2*^*−*/*−*^ mice (and whole-body *bIrs2*^*+*/*−*^. *Irs4*^*−*/*y*^ mice compared to controls [@bib7]), the body weight of obese mice with double deletion of Irs4 and Irs2 in LepRb neurons (*Lepr*^*∆Irs2*/*Irs4−*/*y*^) was indistinguishable from the mice lacking only Irs2 in LepRb neurons (*Lepr*^Δ*Irs2*^). These results suggest that Irs4 effect on weight gain in the brain does not involve LepRb signaling. Indeed, despite the important role of Irs2 in LepRb neurons, and the hyperleptinemia of animals null for Irs2 in LepRb cells, leptin signals normally to decrease body weight in young *Lepr*^*∆Irs2*^-mice [@bib29]. Thus, neither Irs2 nor Irs4 in LepRb neurons is required for leptin action, but rather presumably mediate crucial insulin signals in LepRb cells (Irs2) and non-LepRb cells (Irs2 and Irs4). Insulin action in the hypothalamus mediates important effects upon body weight and nutrient homeostasis through signaling cascades which regulate food intake, glucose and lipid metabolism, and energy expenditure [@bib3]. Both Irs2 and Irs4 are expected to promote the PI3K→Akt ┤FoxO1 cascade in hypothalamic neurons, as elsewhere in the body; this pathway is known to play a crucial role in the hypothalamic control of metabolic regulation [@bib39].

Overall, our results suggest that Irs2 and Irs4 synergize in non-LepRb neurons to mediate central insulin action, thereby controlling a variety of metabolically important phenotypes. While it contributes to the control of energy balance, Irs4 plays an especially crucial role in the control of whole-body insulin sensitivity and glucose homeostasis.
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![*bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^-mice are obese. (A) Average body weights of male *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^-mice (open squares), *Irs4*^*−*/*y*^*-*mice (closed squares), *bIrs2*^*−*/*−*^ mice (open circles) and control *Irs2*^*L*/*L*^ mice (closed circles) on regular chow diet was determined in each age group and compared by generalized linear regression (SPSS, v19). The number of mice in each group is indicated in parentheses (mean±SD; \*, Bonferroni *p*\<0.001). (B) Representative image of 3-months-old male mice. (C) Body length and (D) percent body fat was determined by DEXA using 12-week-old mice (mean±SEM; *n*=8--10/genotype, \**p*\<0.05 vs. controls).](gr1){#f0005}

![Representative H&E staining of (A) white adipose tissue (WAT) and (C) liver sections of 6-month-old *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice, *Irs4*^*−*/*y*^*-*mice, *bIrs2*^*−*/*−*^ or *Irs2*^*L*/*L*^ mice. Liver sections of 9-month-old *ob*/*ob* mice are also shown. (B) Morphometric analysis of adipocyte cell size in epididymal adipose tissue (*n*=5 animals per genotype; \**p*\<0.05 vs. control).](gr2){#f0010}

![Energy expenditure in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice. (A) Serum leptin levels of 9-month-old male *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice, *Irs4*^*−*/*y*^*-*mice, *bIrs2*^*−*/*−*^ mice and *Irs2*^*L*/*L*^ mice (*n*=8--10, mean±SEM; \*, *p*\<0.05 for indicated comparison). (B) Food intake over 24 h in 3-month-old male *bIrs2*^*−*/*−*^*·Irs4*^*−*/*y*^*-*mice, *Irs4*^*−*/*y*^ mice, *bIrs2*^*−*/*−*^-mice or *Irs2*^*L*/*L*^-mice fed regular chow diet (mean±SEM; \* *p*\<0.05 for indicated comparison). Three month-old male mice of the indicated genotype were monitored for 72 h in the CLAMS (*n*=10/genotype) to assess (C) oxygen consumption (O~2~, l/kg/h), and (D) heat production (kcal/h/kg). Dark phase is presented (mean±SD; \* *p*\<0.001 for indicated comparison). Heat production was analyzed by generalized linear regression (SPSS, v19), controlling for the effect of body weight (Bonferroni, *p*\<0.001) and (E) RER (respiratory exchange ratio) during the light and dark phases. (F) Representative H&E staining of brown adipose tissue (BAT) of 3-month-old male *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice, *Irs4*^*−*/*y*^*-*mice, *bIrs2*^*−*/*−*^-mice and *Irs2*^*L*/*L*^-mice.](gr3){#f0015}

![Levels of mRNA (relative to actin) by RT-PCR of *Npy* (A), *Agrp* (B) and *Pomc* (C) from hypothalamus of 3-month-old chow-fed male mice of the indicated genotypes. (D) Ratio between *Agrp* and *Pomc* mRNAs (from B, C) for the indicated genotypes. Data are presented as mean±SEM; \* *p*\<0.05 for indicated comparisons. (*n*=4--5).](gr4){#f0020}

![Glucose homeostasis in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice. (A) Fasted and (B) fed blood glucose for 3 month-old male mice. (C) Glucose tolerance test of 3 month-old male mice (*n*=10/genotype). (D) Insulin tolerance test of 4 month-old male mice (*n*=9--10/genotype). (E) HOMO2-IR index of insulin resistance (IR) and (F) fasting serum insulin levels (*n*=10/genotype) for 9 month-old male mice of the indicated genotypes. Data are expressed as mean±SEM. \* *p*\<0.05 for indicated comparisons.](gr5){#f0025}

![(A) Representative H&E staining of pancreatic sections of *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice, *Irs4*^*−*/*y*^ mice, *bIrs2*^*−*/*−*^ mice and *Irs2*^*L*/*L*^ mice at indicated ages. (B) Quantification of total pancreatic area occupied by *β* cells in *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^ mice, *Irs4*^*−*/*y*^ mice, *bIrs2*^*−*/*−*^ mice and *Irs2*^*L*/*L*^ mice. Data are presented as mean±SEM; \* *p*\<0.05. (*n*=4--5) compared to other genotypes.](gr6){#f0030}

![*Lepr*^*∆Irs2*^*-mice and Lepr*^*∆Irs2*^·*Irs4*^*−*/*y*^*-mice* display similar body weight and normal blood glucose levels. (A) Average body weights of 3 month-old male *bIrs2*^*−*/*−*^·*Irs4*^*−*/*y*^*-*mice, *Irs4*^*−*/*y*^ mice, *bIrs2*^*−*/*−*^ mice, *Irs2*^*L*/*L*^ mice and *Lepr*^*∆Irs2*^*-mice and Lepr*^*∆Irs2*^·*Irs4*^*−*/*y*^*-mice*. (B) Fed blood glucose levels of 3 month-old male *Irs2*^*L*/*L*^ mice, *Lepr*^*∆Irs2*^*-mice and Lepr*^*∆Irs2*^·*Irs4*^*−*/*y*^*-mice.* Mean±SD; *n*=6--8/genotype, \**p*\<0.001 for indicated comparisons.](gr7){#f0035}
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